Immunocore Holdings plc
NASDAQImmunocore Holdings delivered a sharp reversal of its recent slide on Wednesday, rallying more than 10% after Q1 results beat expectations on profitability while revealing a pipeline full of upcoming readouts. The earnings beat was the headline: EPS came in at $0.25 against an estimate of -$0.25, a $0.51 beat. Revenue of $106.7M missed the $107.7M consensus by a thin margin, but…
Snapshot as of 22 Jun 2026
Immunocore Holdings delivered a sharp reversal of its recent slide on Wednesday, rallying more than 10% after Q1 results beat expectations on profitability while revealing a pipeline full of upcoming readouts. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IMCR — free to start on ORTEX.
Sign up for free →Open IMCR on ORTEX